Yet another study exposing the fraud\/myth that somehow “cancer” cells are different and evil and as such the only hope for curing cancer is killing them before they kill their “host”. The central dogma of oncology is that genetic mutations happen first (and randomly so). Then, once a “cancerous” mutation happens the cell is fundamentally changed and all subsequent metabolic and structural derangements are a mere result of these (permanent) mutations. Well, when it comes to lymphoma at least, the study below begs to disagree. It demonstrates that a simple increase in activity of an enzyme involved in serine\/glycine metabolism and also generations of extra methyl groups (which confirms the role of overmethylation in cancer genesis) is fully sufficient to trigger the “cancerization” of a normal B cells into B cell lymphoma. Again, there is no actual “conversion” into a different cell type, there is simply change in behavior due to restrictive\/suboptimal environment and metabolic deficiency. As soon as those are corrected, the “cancer” cells usually revert to “normal”. The authors of the study themselves state so and argue that metabolic therapies hold great promise for treating at least this type of “cancer”. Cancer is, and always has been, nothing but a metabolic derangement. As such, its fraudulent cytotoxic “treatment” over the last 100 years is the biggest genocide in the history of this world!<\/p>\n
https:\/\/www.nature.com\/articles\/s43018-020-0080-0<\/a><\/p>\n Lymphoma-Associated Metabolic Enzyme May Be a Drug Target<\/a><\/p><\/blockquote>\n